GRCE logo

GRCEGrace Therapeutics Inc.

$2.25
$0.01
(0.46%)
Today
Closed $2.21
$0.04
(1.81%)
After Hours
Updated: 07:35 PM EDT
Reported EarningsFeb 12
Mkt Cap$34.04M
Vol365,843.00

About

Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Grace Therapeutics Inc.?
What is the 52-week high for Grace Therapeutics Inc.?
What is the 52-week low for Grace Therapeutics Inc.?
What is Grace Therapeutics Inc. stock price today?
What was Grace Therapeutics Inc. stock price yesterday?
What is the PE ratio of Grace Therapeutics Inc.?
What is the Price-to-Book ratio of Grace Therapeutics Inc.?
What is the 50-day moving average of Grace Therapeutics Inc.?

Advertisement|Remove ads.